脑膜瘤对西斯普拉丁耐药性的遗传影响:孟德尔的随机化分析
Kefu Yu1, Ziming Li2, Weizhong Shi1
1Department of Pharmacy, Beijing Tiantan Hospital Affiliated to Capital Medical University, No. 119 South Fourth Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
International journal of clinical pharmacy
|June 20, 2024
概括
对脑膜瘤的遗传倾向增加了对西斯普拉丁耐药性的风险. 这项门德尔随机化研究突出了潜在的因果关系,需要对潜在机制进行进一步调查.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 对西斯普拉丁的耐药性是癌症治疗中的一个重大挑战.
- 基因变异对西斯普拉丁耐药性的作用,特别是脑膜瘤的作用,仍未得到充分研究.
研究的目的:
- 为了研究脑膜瘤的遗传倾向和西斯普拉丁耐药性之间的因果关系.
- 在这项调查中使用双样本的门德尔随机化 (MR) 方法.
主要方法:
- 采用了两个样本的孟德尔随机化 (MR) 分析.
- 利用了全基因组关联研究 (GWAS) 数据.
- 选择与脑膜瘤相关的单核酸多态 (SNPs) 作为工具变量,以评估与西斯普拉丁耐药性的因果关系.
主要成果:
- 研究人员发现,对脑膜瘤的遗传倾向显著增加了对西斯普拉丁耐药性的风险.
- 这种关联的估计几率比为1.63 (95% CI 1.44-1.85,P < 0.05).
- 敏感性分析证实了因果关系的稳定性.
结论:
- 导致脑膜瘤发展的遗传因素似乎增加了对西斯普拉丁耐药性的敏感性.
- 建议进行进一步的研究,以阐明这种观察到的因果效应背后的特定分子机制.
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


